Showing 1 - 2 of 2
One of the reasons why regulators are hesitant about permitting price competition in healthcare markets is that it may damage quality when information is poor. Evidence on whether this fear is well-founded is scarce. We provide evidence using a reform that permitted Dutch health insurers and...
Persistent link: https://www.econbiz.de/10011823733
Persistent link: https://www.econbiz.de/10009720707